BAM
Bellevue Asset Management’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.9K | Buy |
1,851
+15
| +0.8% | +$364 | 0.02% | 167 |
|
|
2025
Q1 | $46.5K | Buy |
1,836
+14
| +0.8% | +$355 | 0.03% | 160 |
|
|
2024
Q4 | $48.3K | Buy |
1,822
+172
| +10% | +$4.56K | 0.03% | 160 |
|
|
2024
Q3 | $47.8K | Sell |
1,650
-240
| -13% | -$6.95K | 0.02% | 166 |
|
|
2024
Q2 | $52.9K | Sell |
1,890
-1,135
| -38% | -$31.8K | 0.03% | 144 |
|
|
2024
Q1 | $84K | Sell |
3,025
-21
| -0.7% | -$583 | 0.05% | 108 |
|
|
2023
Q4 | $87.7K | Sell |
3,046
-167
| -5% | -$4.81K | 0.08% | 104 |
|
|
2023
Q3 | $107K | Buy |
3,213
+3
| +0.1% | +$100 | 0.07% | 83 |
|
|
2023
Q2 | $118K | Buy |
3,210
+2
| +0.1% | +$73 | 0.07% | 79 |
|
|
2023
Q1 | $131K | Buy |
3,208
+2
| +0.1% | +$82 | 0.09% | 77 |
|
|
2022
Q4 | $163K | Buy |
3,206
+1
| +0% | +$51 | 0.13% | 67 |
|
|
2022
Q3 | $140K | Buy |
3,205
+3
| +0.1% | +$131 | 0.11% | 80 |
|
|
2022
Q2 | $169K | Buy |
3,202
+1
| +0% | +$53 | 0.12% | 71 |
|
|
2022
Q1 | $167K | Buy |
3,201
+2
| +0.1% | +$104 | 0.1% | 80 |
|
|
2021
Q4 | $189K | Sell |
3,199
-231
| -7% | -$13.6K | 0.11% | 72 |
|
|
2021
Q3 | $149K | Buy |
3,430
+1
| +0% | +$43 | 0.09% | 89 |
|
|
2021
Q2 | $134K | Sell |
3,429
-398
| -10% | -$15.6K | 0.08% | 100 |
|
|
2021
Q1 | $139K | Buy |
3,827
+1,147
| +43% | +$41.7K | 0.09% | 100 |
|
|
2020
Q4 | $100K | Sell |
2,680
-615
| -19% | -$22.9K | 0.06% | 112 |
|
|
2020
Q3 | $121K | Buy |
3,295
+24
| +0.7% | +$881 | 0.08% | 98 |
|
|
2020
Q2 | $107K | Sell |
3,271
-40
| -1% | -$1.31K | 0.11% | 105 |
|
|
2020
Q1 | $126K | Buy |
3,311
+163
| +5% | +$6.2K | 0.13% | 96 |
|
|
2019
Q4 | $123K | Buy |
+3,148
| New | +$123K | 0.09% | 98 |
|